F.NO. 8 (43)/2002/DP/NPPA-Div.II
GOVERNMENT OF INDIA
MINISTRY OF CHEMICALS AND FERTILIZERS
NATIONAL PHARMACEUTICAL PRICING AUTHORITY
NEW DELHI, DATED THE 9/9/2002
ORDER
In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 of the Drugs (Price Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority hereby fixes/revises the prices as specified in column (7) of the Table hereto annexed as the retail price/revised retail price, exclusive of local tax if any, in relation to each of the formulations specified in the corresponding entry in column (2) of the said Table with pack size specified in the corresponding entries in column (3) thereof;
TABLE
Sl. No. | Name of the Formulation | Pack Size | Existing Retail Price (Rs.) | Retail Price without Excise Duty | Excise Duty (Rs.) | Revised Retail Price with Excise Duty (Rs.) |
---|---|---|---|---|---|---|
1 | Human Longact Each ml contains Insulin Human USP 40 IHU Methyl paraben 0.1% w/v Water for Inj. Q.S. |
10ml Vial | 200.94 | 220.88 | 0.00 | 220.88 |
2 | Human Mixact 50 : 50 Each ml contains Insulin Human USP 40 IHU (soluble Insulin Human 20 IHU /ml and crystalline Insulin Human 20IHUml ) Meta Cresol USP 0.16% w/v Phenol IP-0.065% w/v ( as preservative) Water for Inj. Q.S. |
10ml Vial | 199.56 | 219.24 | 0.00 | 219.24 |
3 | Human Mixact 30 : 70 Each ml contains Insulin Human USP 40 IHU (soluble Insulin Human 12 IHU /ml and crystalline Insulin Human 28 IHUml ) Meta Cresol USP 0.16% w/v Phenol IP-0.065%w/v ( as preservative) Water for Inj. Q.S. |
10ml Vial | 199.46 | 219.26 | 0.00 | 219.26 |
4 | Human Fastact Each ml contains Insulin Human USP 40 IHU Meta Cresol-0.25% w/v Water for Inj. Q.S. |
90’s Glass_Bottle | 199.24 | 218.96 | 0.00 | 218.96 |
5 | Bovine-Longact (Highly Purified Bovine Insulin) Each ml contains Insulin IP 40 IU Methyl paraben 0.1% w/v Water for Inj. Q.S. |
90’s Glass_Bottle | 66.70 | 72.78 | 0.00 | 72.78 |
6 | Bovine-Fastact (Highly Purified Bovine Insulin) Each ml contains Insulin IP 40 IU Meta Cresol – 0.25% w/v Water for Inj. Q.S. |
90’s Glass_Bottle | 65.00 | 70.86 | 0.00 | 70.86 |
7 | Bovine-Mixact (Highly Purified Bovine Insulin) Each ml contains Insulin IP 40 IU (Soluble Insulin -12 IU/ml and Crystalline Insulin 28 IU/ml ) Meta Cresol – 0.16% w/v Phenol IP – 0.065% W/V Water for Inj. Q.S. |
10ml Vial | 65.16 | 71.16 | 0.00 | 71.16 |
8 | Porcine-Mixact (Monocomponent Porcine Insulin) Each ml contains Insulin IP 40 IU (Soluble Insulin -12 IU/ml and Crystalline Insulin 28 IU/ml ) Meta Cresol – 0.16% w/v Phenol IP – 0.065% W/V Water for Inj. Q.S. |
10ml Vial | 129.02 | 145.14 | 0.00 | 145.14 |
9 | Porcine-Longact (Monocomponent Porcine Insulin) Each ml contains Insulin IP 40 IU Methyl Paraben – 0.1% W/V Water for Inj. Q.S. |
10ml Vial | 130.54 | 146.78 | 0.00 | 146.78 |
10 | Porcine-Fastact (Monocomponent Porcine Insulin) Each ml contains Insulin IP 40 IU Meta Cresol – 0.25% w/v Water for Inj. Q.S. |
10ml Bottle | 128.26 | 144.86 | 0.00 | 144.86 |
- This order shall be applicable if the manufacturer of the formulation specified in column (2) of the Table above has complied with the requirements, if any, of
(a) the Drugs and Cosmetics Act, 1940 (23 of 1940) and the rules made thereunder; and
(b) the Industries (Development and Regulation) Act, 1951 (65 of 1951) as amended from time to time.
3.(a) The prices fixed/revised are the maximum retail prices (inclusive of excise duty and exclusive of local taxes, if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(b) For different packing material used or any special feature claimed, companies are required to approach NPPA for approval/fixation of specific prices.
- These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.
(S.K. BHATT)
Dy. Director
PN/65/2002/F
M/s M.J. Biopharma Pvt. Ltd.
(Formlely known as Shreya Healthcare Pvt. Ltd.)
113, Jolly Maker, Chambers No. 2,
Nariman Point
Mumbai-400021
Last Page Updated: 31-05-2019
Copyright © 2023 - All Rights Reserved- Official Website of National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Government of India
Note :Website Content Managed by National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Designed, Developed and Hosted by National Informatics Centre Services Inc.(NICSI)